Annual Working Capital
$45.60 M
-$24.71 M-35.15%
31 December 2022
Summary:
Zynerba Pharmaceuticals annual working capital is currently $45.60 million, with the most recent change of -$24.71 million (-35.15%) on 31 December 2022. During the last 3 years, it has fallen by -$13.85 million (-23.30%).ZYNE Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Working Capital
$27.84 M
-$10.13 M-26.67%
30 June 2023
Summary:
Zynerba Pharmaceuticals quarterly working capital is currently $27.84 million, with the most recent change of -$10.13 million (-26.67%) on 30 June 2023.ZYNE Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ZYNE Working Capital Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | - |
| 3 y3 years | -23.3% | -63.9% |
| 5 y5 years | -20.3% | -67.1% |
ZYNE Working Capital High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | ||||
| 5 y | 5 years | ||||
| alltime | all time | -39.2% | -70.6% |
Zynerba Pharmaceuticals Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| June 2023 | - | $27.84 M(-26.7%) |
| Mar 2023 | - | $37.97 M(-16.7%) |
| Dec 2022 | $45.60 M(-35.1%) | $45.60 M(-11.2%) |
| Sept 2022 | - | $51.37 M(-8.5%) |
| June 2022 | - | $56.14 M(-12.7%) |
| Mar 2022 | - | $64.31 M(-8.5%) |
| Dec 2021 | $70.32 M(+18.3%) | $70.32 M(-8.9%) |
| Sept 2021 | - | $77.16 M(-10.7%) |
| June 2021 | - | $86.43 M(-8.7%) |
| Mar 2021 | - | $94.63 M(+59.2%) |
| Dec 2020 | $59.45 M(-20.7%) | $59.45 M(-7.4%) |
| Sept 2020 | - | $64.19 M(-11.2%) |
| June 2020 | - | $72.28 M(+11.6%) |
| Mar 2020 | - | $64.76 M(-13.6%) |
| Dec 2019 | $75.00 M(+31.0%) | $75.00 M(-11.3%) |
| Sept 2019 | - | $84.52 M(+1.1%) |
| June 2019 | - | $83.59 M(+25.2%) |
| Mar 2019 | - | $66.75 M(+16.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2018 | $57.23 M(-5.8%) | $57.23 M(-9.9%) |
| Sept 2018 | - | $63.54 M(+68.3%) |
| June 2018 | - | $37.75 M(-23.1%) |
| Mar 2018 | - | $49.06 M(-19.3%) |
| Dec 2017 | $60.78 M(+106.4%) | $60.78 M(-5.7%) |
| Sept 2017 | - | $64.45 M(-6.0%) |
| June 2017 | - | $68.59 M(-10.2%) |
| Mar 2017 | - | $76.42 M(+159.6%) |
| Dec 2016 | $29.44 M(-25.4%) | $29.44 M(-3.7%) |
| Sept 2016 | - | $30.58 M(+0.1%) |
| June 2016 | - | $30.56 M(-14.2%) |
| Mar 2016 | - | $35.61 M(-9.8%) |
| Dec 2015 | $39.48 M(+367.2%) | $39.48 M(-10.6%) |
| Sept 2015 | - | $44.15 M(+741.5%) |
| June 2015 | - | $5.25 M(-24.6%) |
| Mar 2015 | - | $6.95 M(-17.7%) |
| Dec 2014 | $8.45 M(-1067.6%) | $8.45 M |
| Dec 2013 | -$873.20 K | - |
FAQ
- What is Zynerba Pharmaceuticals annual working capital?
- What is the all time high annual working capital for Zynerba Pharmaceuticals?
- What is Zynerba Pharmaceuticals quarterly working capital?
- What is the all time high quarterly working capital for Zynerba Pharmaceuticals?
What is Zynerba Pharmaceuticals annual working capital?
The current annual working capital of ZYNE is $45.60 M
What is the all time high annual working capital for Zynerba Pharmaceuticals?
Zynerba Pharmaceuticals all-time high annual working capital is $75.00 M
What is Zynerba Pharmaceuticals quarterly working capital?
The current quarterly working capital of ZYNE is $27.84 M
What is the all time high quarterly working capital for Zynerba Pharmaceuticals?
Zynerba Pharmaceuticals all-time high quarterly working capital is $94.63 M